Menu

Image of the Day: Calcium Signaling

Researchers used light-sheet microscopy to form 3-D images of the process in primary cortical neurons from embryonic rats.

Feb 20, 2018
The Scientist Staff, The Scientist Staff

Calcium signaling in primary cortical neurons from embryonic rats imaged in 3-D with parallelized light-sheet microscopyK.M. DEAN ET AL.

To acquire an image of calcium signaling, Reto Fiolka, a cell biologist at the University of Texas Southwestern Medical Center, illuminated primary cortical neurons from embryonic rats with three separate light sheets using fluorescence microscopy. Each light sheet was detected independently, and they were combined to produce a 3-D image of calcium signaling. The novel technology allows the visualization of rapid microscopic events in three dimensions, and the researchers also used it to demonstrate other intracellular and biological processes. 

K.M. Dean et al., “Imaging subcellular dynamics with fast and light-efficient volumetrically parallelized microscopy,” Optica, doi:10.1364/OPTICA.4.000263, 2017.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.